The improvements in spatial memory and LTP following PU-AD treatment in APP NL-F mice provide strong evidence confirming the direct role of epichaperomes in driving synaptic dysfunction and cognitive impairment across the AD continuum. This evidence concerns the gene APP and Alzheimer disease.